Back to search

Aristotle University Of Thessaloniki (AUTH)

Αξιολόγηση της διαχείρισης των ασθενών με αναπνευστικά νοσήματα

Abstract

dc:description

Background: The prevalence of respiratory diseases has increased significantly in recent years despite the new advanced treatments which are currently used. The burden of these diseases on health systems worldwide is enormous and considering the large under diagnosis rates recorded, then the cost is incalculable. Aim: The aim of this study was to make an attempt to estimate the direct and indirect costs of lung cancer (LC), chronic obstructive pulmonary (COPD) disease and bronchial asthma (BA) since in Greece very few attempts have been done to measure these costs and data available are insufficient. Our research focused on evaluating these direct and indirect costs according to demographic factors, stage and type of disease, response to treatment, patient survival, quality of life and patient satisfaction from the health care services provided. This study also focused on the comparison between the three respiratory diseases to investigate which constitutes the higher burden for health systems. Method: This study was performed in Pulmonary Department of Aristotle University of Thessaloniki, ‘G. Papanikolaou’ General Hospital and 321 patients with LC (113), COPD (110) and BA (98) were enrolled. The follow-up duration of the patients was two years from the time of diagnosis. Results: The total mean costs per patient in a one year follow-up was greater for patients with LC (total direct cost: 11.545,20€, total mean indirect cost: 170,12€) than patients with COPD (total mean direct cost: 3.889,08€, total mean indirect cost: 18,01€) and patients with BA (total mean direct cost: 826,11€, total mean indirect cost: 15,67€). In LC, the higher costs were observed in patients diagnosed with metastatic disease and adenocarcinoma, and were related the more cycles of chemotherapy. Both in COPD and BA the disease severity, the frequency of exacerbations and the need for hospitalization significantly increased the economic burden of Greek health care system. In all three respiratory diseases under study, the increase of the medication and patients’ monitoring cost resulted in improved control of the disease. Better quality of life was related to higher direct and indirect costs. In contrast, improved quality of life in COPD and BA patients was related with reduced direct and indirect costs. Only monitoring costs seemed to increase as lung cancer patients’ quality of life improved. Patient satisfaction from the provided health services could not be assessed as there was no homogeneity among the questions of the questionnaire used for the study. Conclusions: In conclusion, patients with LC burden are significantly higher compared to the other two respiratory diseases in the first year of follow-up. However, given the limited survival time of LC patients, it is obvious that the cost of the other two respiratory diseases burdens the health systems cumulatively over time. The higher annual burden of COPD patients compared to patients suffering from BA, is probably due to the infectious exacerbations COPD patients experience, which usually leads them to hospitalization.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Zarogoulidou, Vasiliki
  • Ζαρογουλίδου, Βασιλική

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/38002

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Zarogoulidou, Vasiliki; Ζαρογουλίδου, Βασιλική. Αξιολόγηση της διαχείρισης των ασθενών με αναπνευστικά νοσήματα. Aristotle University Of Thessaloniki (AUTH), 2016. http://hdl.handle.net/10442/hedi/38002